These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20824817)

  • 1. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients.
    Nakajima S; Iijima H; Shinzaki S; Egawa S; Inoue T; Mukai A; Hayashi Y; Kondo J; Akasaka T; Nishida T; Kanto T; Morii E; Mizushima T; Miyoshi E; Tsujii M; Hayashi N
    Inflamm Bowel Dis; 2011 Apr; 17(4):927-36. PubMed ID: 20824817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease.
    Shinzaki S; Kuroki E; Iijima H; Tatsunaka N; Ishii M; Fujii H; Kamada Y; Kobayashi T; Shibukawa N; Inoue T; Tsujii M; Takeishi S; Mizushima T; Ogata A; Naka T; Plevy SE; Takehara T; Miyoshi E
    Inflamm Bowel Dis; 2013 Feb; 19(2):321-31. PubMed ID: 23287897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.
    Inoue T; Iijima H; Tajiri M; Shinzaki S; Shiraishi E; Hiyama S; Mukai A; Nakajima S; Iwatani H; Nishida T; Mizushima T; Yasui T; Isaka Y; Kanto T; Tsujii M; Miyoshi E; Wada Y; Takehara T
    Inflamm Bowel Dis; 2012 Sep; 18(9):1723-34. PubMed ID: 22241690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes.
    Safaie P; Ham M; Kuang P; Mehta AS; Wang M; Cheifetz AS; Robson S; Lau D; Block TM; Moss AC
    Inflamm Bowel Dis; 2013 Dec; 19(13):2796-800. PubMed ID: 24185312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
    Dubé R; Rook GA; Steele J; Brealey R; Dwek R; Rademacher T; Lennard-Jones J
    Gut; 1990 Apr; 31(4):431-4. PubMed ID: 2338269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Zhang W; Teng G; Wu T; Tian Y; Wang H
    Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.
    Kovacs M; Papp M; Lakatos PL; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Molnar K; Szabo D; Cseh A; Muller KE; Dezsofi A; Arato A; Veres G
    J Crohns Colitis; 2013 Mar; 7(2):134-41. PubMed ID: 22504031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
    Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
    J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC.
    Stucchi A; Reed K; O'Brien M; Cerda S; Andrews C; Gower A; Bushell K; Amar S; Leeman S; Becker J
    Inflamm Bowel Dis; 2006 Jul; 12(7):581-7. PubMed ID: 16804395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
    World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
    Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
    Zhang P; Liu X; Guo A; Xiong J; Fu Y; Zou K
    Dig Dis Sci; 2016 Sep; 61(9):2608-18. PubMed ID: 27056038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
    Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
    Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic variants of mannan-binding (MBL) lectin-2 gene, MBL levels and function in ulcerative colitis and Crohn's disease.
    Sivaram G; Tiwari SK; Bardia A; Manoj G; Santhosh B; Saikant R; Aejaz H; Vishnupriya S; Khan AA; Habibullah C
    Innate Immun; 2011 Dec; 17(6):526-31. PubMed ID: 21088049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease.
    Rector A; Lemey P; Laffut W; Keyaerts E; Struyf F; Wollants E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2001 Oct; 2(6):323-8. PubMed ID: 11607788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.